Concepedia

Thuy Vu

TV

12

Publications

846

Citations

12

H-Index

2009

Active since

Affiliations

Amgen (United States)(Current)

University of Auckland

GlaxoSmithKline (China)

KU Leuven

Oregon Health & Science University

Thuy Vu is an author at Amgen (United States) specializing in autoimmunity, medicine, and autoimmune disease.

Top concepts

Publications per year

2009–2018

12

Publications

12

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

Thuy Vu, John G. Nutt, Nicholas H. G. Holford · British Journal of Clinical Pharmacology · 2012 · 180 citations

Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine

Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen et al. · Clinical Pharmacology & Therapeutics · 2017 · 95 citations · Full text

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper et al. · The Journal of Headache and Pain · 2018 · 94 citations · Full text

Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects

Thuy Vu, Peiming Ma, Jiyun Sunny Chen et al. · Pharmaceutical Research · 2017 · 93 citations · Full text

Population Pharmacokinetics of Golimumab, an Anti‐Tumor Necrosis Factor‐α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis

Zhenhua Xu, Thuy Vu, Howard Lee et al. · The Journal of Clinical Pharmacology · 2009 · 90 citations

Rows per page

1–5 of 12